Li J - Search Results

1

Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment.

Li J, Zhu L, Kwok HF. Li J, et al. Drug Resist Updat. 2023 Jan;66:100904. doi: 10.1016/j.drup.2022.100904. Epub 2022 Nov 28. Drug Resist Updat. 2023. PMID: 36462375 Review.

2

Role of Endothelial ADAM17 in Early Vascular Changes Associated with Diabetic Retinopathy.

Shalaby L, Thounaojam M, Tawfik A, Li J, Hussein K, Jahng WJ, Al-Shabrawey M, Kwok HF, Bartoli M, Gutsaeva D. Shalaby L, et al. Among authors: li j. J Clin Med. 2020 Feb 2;9(2):400. doi: 10.3390/jcm9020400. J Clin Med. 2020. PMID: 32024241 Free PMC article.

3

Current Strategies for Treating NSCLC: From Biological Mechanisms to Clinical Treatment.

Li J, Kwok HF. Li J, et al. Cancers (Basel). 2020 Jun 15;12(6):1587. doi: 10.3390/cancers12061587. Cancers (Basel). 2020. PMID: 32549388 Free PMC article. Review.

4

RUNDC3A regulates SNAP25-mediated chemotherapy resistance by binding AKT in gastric neuroendocrine carcinoma (GNEC).

Chen P, Wang W, Wong SW, Li J, Wu Q, Zhang SD, Lin Y, Kwok HF. Chen P, et al. Among authors: li j. Cell Death Discov. 2022 Jun 25;8(1):296. doi: 10.1038/s41420-022-01084-4. Cell Death Discov. 2022. PMID: 35752613 Free PMC article.

5

A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axis.

Li J, Chen P, Wu Q, Guo L, Leong KW, Chan KI, Kwok HF. Li J, et al. Cell Mol Life Sci. 2022 Dec 2;79(12):614. doi: 10.1007/s00018-022-04647-x. Cell Mol Life Sci. 2022. PMID: 36456730

6

Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy.

Zhu L, Li J, Guo Z, Kwok HF, Zhao Q. Zhu L, et al. Among authors: li j. J Nanobiotechnology. 2022 Dec 10;20(1):521. doi: 10.1186/s12951-022-01736-8. J Nanobiotechnology. 2022. PMID: 36496381 Free PMC article.

7

Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin α5/β1-FAK/Src axis: A novel strategy for drug application.

Wu Q, Chen P, Li J, Lin Z, Zhang Q, Kwok HF. Wu Q, et al. Among authors: li j. Pharmacol Res. 2023 Feb;188:106654. doi: 10.1016/j.phrs.2023.106654. Epub 2023 Jan 11. Pharmacol Res. 2023. PMID: 36640858 Free article.

8

Nanoenabled intracellular zinc bursting for efficacious reversal of gefitinib resistance in lung cancer.

Li J, Assaraf YG, Zuo W, Lin Z, Leong KW, Zhao Q, Zhu L, Kwok HF. Li J, et al. Int J Biol Sci. 2024 May 19;20(8):3028-3045. doi: 10.7150/ijbs.95929. eCollection 2024. Int J Biol Sci. 2024. PMID: 38904022 Free PMC article.

9

Self-catalyzed nitric oxide nanocomplexes induce ferroptosis for cancer immunotherapy.

Zhu L, Leng D, Guo Z, Zhao Y, Leung KT, Dai Y, Li J, Zhao Q. Zhu L, et al. Among authors: li j. J Control Release. 2025 Jan 10;377:524-539. doi: 10.1016/j.jconrel.2024.11.048. Epub 2024 Nov 28. J Control Release. 2025. PMID: 39580079

10

Oral Immunization of Mice with a Nonantibiotic Recombinant Lactobacillus plantarum Coexpressing Trichinella spiralis TsNd and gp43 Protein Vaccine Combined with a Murine Interleukin-33 Adjuvant.

Li HY, Wang D, Xie QY, Liu X, Li JY, Huang HB, Wang N, Shi CW, Pan TX, Li MH, Zhao DY, Yu SY, Guan JY, Yang GL. Li HY, et al. Among authors: li jy. Foodborne Pathog Dis. 2024 Dec 24. doi: 10.1089/fpd.2024.0125. Online ahead of print. Foodborne Pathog Dis. 2024. PMID: 39718603

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193,275 results

Search Page

Filters